Faruqi & Faruqi, LLP Announces Preliminary Court Approval of Settlement in McIntyre v. Chelsea Therapeutics International, Ltd., et al.


Faruqi & Faruqi LLP is pleased to announce the Court’s preliminary approval of a settlement in MacIntyre v. Chelsea Therapeutics International, Ltd., et al., Case No. 3:12-CV-213-MOC-DCK (W.D.N.C.).  The settlement provides for $5,500,000 in cash to be paid to class members who purchased or otherwise acquired Chelsea common stock between September 20, 2010 and May 21, 2012, both dates inclusive.  A final approval hearing on the settlement will be held on September 19, 2016, at 10:00 a.m., at the United States District Court for the Western District of North Carolina.  Notice will be provided to class members in the upcoming weeks, and information about the settlement will also be posted online at www.ChelseaTherapeuticsSettlement.com.  In the meantime, a copy of the Court’s order preliminarily approving the settlement can be found at the link below.

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania